Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study

M. Arabi, Yaseen; Shalhoub, Sarah; Mandourah, Yasser; Al-Hameed, Fahad; Al‐Omari, Awad; Al Qasim, Eman; Jose, Jesna; Alraddadi, Basem; Almotairi, Abdullah; Al Khatib, Kasim; Abdulmomen, Ahmed; Qushmaq, Ismael; Sindi, Anees; Mady, Ahmed; Solaiman, Othman; Al‐Raddadi, Rajaa; Maghrabi, Khalid; Ragab, Ahmed; A. Al Mekhlafi, Ghaleb; H. Balkhy, Hanan; Al Harthy, Abdulrahman; Kharaba, Ayman; Gramish, Jawaher; M. Al‐Aithan, Abdulsalam; Al‐Dawood, Abdulaziz; Merson, Laura; G. Hayden, Frederick; Fowler, Robert

doi:10.1093/cid/ciz544

Public

Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study

Published in Clinical Infectious Diseases • Jun 25, 2019

Authors:

Yaseen M. Arabi

Sarah Shalhoub

Yasser Mandourah

Abstract

BACKGROUND: The objective of this study was to evaluate the effect of ribavirin and recombinant interferon (RBV/rIFN) therapy on the outcomes of critically ill patients with Middle East respiratory syndrome (MERS), accounting for time-varying confounders. METHODS: This is a retrospective cohort stud...

Subject

Medicine

Ribavirin

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!